Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan van Riggelen

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nature Cell Biology|December 23, 2009
Myc and a Cdk2 senescence switchJan van Riggelen, Dean W Felsher
Genes|May 16, 2017
MYC-Master Regulator of the Cancer Epigenome and TranscriptomeCandace J Poole, Jan van Riggelen
Nature Reviews. Cancer|March 25, 2010
MYC as a regulator of ribosome biogenesis and protein synthesisJan van Riggelen, Alper Yetil, Dean W Felsher
Epigenetics & Chromatin|July 4, 2019
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALLCandace J Poole, Atul Lodh, Jeong-Hyeon Choi, et al.
Cellular Immunology|June 22, 2021
Expression regulation and function of PD-1 and PD-L1 in T lymphoma cellsMaria Y Liu, John D Klement, Candace J Langan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2007
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivationChi-Hwa Wu, Jan van Riggelen, Alper Yetil, et al.
Cancers|November 21, 2018
Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 InhibitionCandace J Poole, Wenli Zheng, Haesung Lee, et al.
Journal of Virology|December 12, 2001
Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cellsAnastasia Bachmann, Brigitte Hanke, Rainer Zawatzky, et al.
The Journal of Biological Chemistry|August 17, 2004
Ectopic expression of nonliganded retinoic acid receptor beta abrogates AP-1 activity by selective degradation of c-Jun in cervical carcinoma cellsJohanna De-Castro Arce, Ubaldo Soto, Jan van Riggelen, et al.
Oncogene|August 25, 2019
Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicityAhmet Alptekin, Bingwei Ye, Yajie Yu, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nature Cell Biology|December 23, 2009
Myc and a Cdk2 senescence switchJan van Riggelen, Dean W Felsher
Genes|May 16, 2017
MYC-Master Regulator of the Cancer Epigenome and TranscriptomeCandace J Poole, Jan van Riggelen
Nature Reviews. Cancer|March 25, 2010
MYC as a regulator of ribosome biogenesis and protein synthesisJan van Riggelen, Alper Yetil, Dean W Felsher
Epigenetics & Chromatin|July 4, 2019
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALLCandace J Poole, Atul Lodh, Jeong-Hyeon Choi, et al.
Cellular Immunology|June 22, 2021
Expression regulation and function of PD-1 and PD-L1 in T lymphoma cellsMaria Y Liu, John D Klement, Candace J Langan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2007
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivationChi-Hwa Wu, Jan van Riggelen, Alper Yetil, et al.
Cancers|November 21, 2018
Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 InhibitionCandace J Poole, Wenli Zheng, Haesung Lee, et al.
Journal of Virology|December 12, 2001
Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cellsAnastasia Bachmann, Brigitte Hanke, Rainer Zawatzky, et al.
The Journal of Biological Chemistry|August 17, 2004
Ectopic expression of nonliganded retinoic acid receptor beta abrogates AP-1 activity by selective degradation of c-Jun in cervical carcinoma cellsJohanna De-Castro Arce, Ubaldo Soto, Jan van Riggelen, et al.
Oncogene|August 25, 2019
Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicityAhmet Alptekin, Bingwei Ye, Yajie Yu, et al.
Pageof 2